Browse by UCL people
Group by: Type | Date
Jump to: Article
Number of items: 83.
Article
Altmann, P;
De Simoni, D;
Kaider, A;
Ludwig, B;
Rath, J;
Leutmezer, F;
Zimprich, F;
... Rommer, PS; + view all
(2020)
Increased serum neurofilament light chain concentration indicates poor outcome in Guillain-Barré syndrome.
Journal of Neuroinflammation
, 17
, Article 86. 10.1186/s12974-020-01737-0.
|
 |
|
Arends, Samuel;
Drenthen, Judith;
van den Bergh, Peter;
Franssen, Hessel;
Hadden, Robert DM;
Islam, Badrul;
Kuwabara, Satoshi;
... Cornblath, David R; + view all
(2022)
Electrodiagnosis of Guillain-Barre syndrome in the International GBS Outcome Study: Differences in methods and reference values.
Clinical Neurophysiology
, 138
pp. 231-240.
10.1016/j.clinph.2021.12.014.
|
|
Arthur-Farraj, PJ;
Murphy, SM;
Laura, M;
Lunn, MP;
Manji, H;
Blake, J;
Ramdharry, G;
... Reilly, MM; + view all
(2012)
Hand weakness in Charcot-Marie-Tooth disease 1X.
Neuromuscular Disorders
, 22
(7)
622 - 626.
10.1016/j.nmd.2012.02.008.
|
 |
|
Arulkumaran, N;
Snow, TAC;
Kulkarni, A;
Brealey, D;
Rickman, H;
Rees-Spear, C;
Spyer, MJ;
... Singer, M; + view all
(2021)
Defining Potential Therapeutic Targets in Coronavirus Disease 2019: A Cross-Sectional Analysis of a Single-Center Cohort.
Critical Care Explorations
, 3
(8)
, Article e0488. 10.1097/cce.0000000000000488.
|
|
|
Arulkumaran, N;
Snow, TAC;
Kulkarni, A;
Brealey, D;
Rickman, HM;
Rees-Spear, C;
Spyer, MJ;
... Singer, M; + view all
(2021)
Influence of IL-6 levels on patient survival in COVID-19.
Journal of Critical Care
, 66
pp. 123-125.
10.1016/j.jcrc.2021.08.013.
|
|
|
Arulkumaran, N;
Snow, TAC;
Kulkarni, A;
Brealey, D;
Rickman, HM;
Rees-Spear, C;
Spyer, MJ;
... Singer, M; + view all
(2021)
Sex differences in immunological responses to COVID-19: a cross-sectional analysis of a single-centre cohort.
British Journal of Anaesthesia
10.1016/j.bja.2021.05.013.
(In press).
|
|
|
Arulkumaran, N;
Thomas, M;
Brealey, D;
Alwan, F;
Singh, D;
Lunn, M;
Welch, A;
... Scully, M; + view all
(2021)
Plasma exchange for COVID-19 thrombo-inflammatory disease.
EJHaem
, 2
(1)
pp. 26-32.
10.1002/jha2.140.
|
|
|
Banerjee, G;
Ambler, G;
Keshavan, A;
Paterson, RW;
Foiani, MS;
Toombs, J;
Heslegrave, A;
... Werring, DJ; + view all
(2020)
Cerebrospinal fluid biomarkers in cerebral amyloid angiopathy.
Journal of Alzheimer's Disease
, 74
(4)
pp. 1189-1201.
10.3233/JAD-191254.
(In press).
|
|
Banerjee, G;
Forsgard, N;
Ambler, G;
Keshavan, A;
Paterson, RW;
Foiani, MS;
Toombs, J;
... Werring, DJ; + view all
(2021)
Cerebrospinal fluid metallomics in cerebral amyloid angiopathy: an exploratory analysis.
Journal of Neurology
10.1007/s00415-021-10711-6.
(In press).
|
|
|
Benjamin, LA;
Paterson, RW;
Moll, R;
Pericleous, C;
Brown, R;
Mehta, PR;
Athauda, D;
... Efthymiou, M; + view all
(2021)
Antiphospholipid antibodies and neurological manifestations in acute COVID-19: A single-centre cross-sectional study.
EClinicalMedicine
, Article 101070. 10.1016/j.eclinm.2021.101070.
(In press).
|
|
|
Bodi, I;
Hagen, EM;
Ingle, GT;
Lunn, MP;
(2020)
Fatal autonomic failure due to premanifesting Parkinson's disease only diagnosed at autopsy.
Clinical Case Reports
, 8
(10)
pp. 1997-1999.
10.1002/ccr3.3042.
|
|
|
Brown, Rachel L;
Benjamin, Laura;
Lunn, Michael P;
Bharucha, Tehmina;
Zandi, Michael S;
Hoskote, Chandrashekar;
McNamara, Patricia;
(2023)
Pathophysiology, diagnosis, and management of neuroinflammation in covid-19.
BMJ
, 382
, Article e073923. 10.1136/bmj-2022-073923.
|
|
Caimari, F;
Keddie, S;
Lunn, MP;
D'Sa, S;
Baldeweg, SE;
(2018)
Prevalence and course of endocrinopathy in POEMS syndrome.
The Journal of Clinical Endocrinology & Metabolism
10.1210/jc.2018-01516.
(In press).
|
|
Chen, LY;
Keddie, S;
Lunn, MP;
Bomsztyk, J;
Vitsaras, E;
Gupta, R;
D'Sa, S;
(2020)
IgM paraprotein-associated peripheral neuropathy: small CD20-positive B-cell clones may predict a monoclonal gammopathy of neurological significance and rituximab responsiveness.
British Journal of Haematology
, 188
(4)
pp. 511-515.
10.1111/bjh.16210.
|
|
Cottenie, E;
Kochanski, A;
Jordanova, A;
Bansagi, B;
Zimon, M;
Horga, A;
Jaunmuktane, Z;
... Houlden, H; + view all
(2014)
Truncating and missense mutations in IGHMBP2 cause Charcot-Marie Tooth disease type 2.
Am J Hum Genet
, 95
(5)
590 - 601.
10.1016/j.ajhg.2014.10.002.
|
|
|
Craven, CL;
Baudracco, I;
Zetterberg, H;
Lunn, MPT;
Chapman, MD;
Lakdawala, N;
Watkins, LD;
(2017)
The predictive value of T-tau and AB1-42 levels in idiopathic normal pressure hydrocephalus.
Acta Neurochirurgica
, 159
(12)
pp. 2293-2300.
10.1007/s00701-017-3314-x.
|
|
Cunningham, EL;
McGuinness, B;
McAuley, DF;
Toombs, J;
Mawhinney, T;
O'Brien, S;
Beverland, D;
... Passmore, AP; + view all
(2019)
CSF Beta-amyloid 1-42 Concentration Predicts Delirium Following Elective Arthroplasty Surgery in an Observational Cohort Study.
Annals of Surgery
, 269
(6)
pp. 1200-1205.
10.1097/SLA.0000000000002684.
|
|
Currò, R;
Salvalaggio, A;
Tozza, S;
Gemelli, C;
Dominik, N;
Galassi Deforie, V;
Magrinelli, F;
... Cortese, A; + view all
(2021)
RFC1 expansions are a common cause of idiopathic sensory neuropathy.
Brain
10.1093/brain/awab072.
(In press).
|
|
|
D'Sa, S;
Kersten, MJ;
Castillo, JJ;
Dimopoulos, M;
Kastritis, E;
Laane, E;
Leblond, V;
... Lunn, MP; + view all
(2017)
Investigation and management of IgM and Waldenström-associated peripheral neuropathies: recommendations from the IWWM-8 consensus panel.
British Journal of Haematology
, 176
(5)
pp. 728-742.
10.1111/bjh.14492.
|
|
|
Doets, Alex Y;
Walgaard, Christa;
Lingsma, Hester F;
Islam, Badrul;
Papri, Nowshin;
Yamagishi, Yuko;
Kusunoki, Susumu;
... Jacobs, Bart C; + view all
(2022)
International Validation of the Erasmus Guillain–Barré Syndrome Respiratory Insufficiency Score.
Annals of Neurology
, 91
(4)
pp. 521-531.
10.1002/ana.26312.
|
|
Ehler, J;
Petzold, A;
Wittstock, M;
Kolbaske, S;
Gloger, M;
Henschel, J;
Heslegrave, A;
... Sauer, M; + view all
(2019)
Correction: The prognostic value of neurofilament levels in patients with sepsis-associated encephalopathy - A prospective, pilot observational study.
PLoS One
, 14
(2)
, Article e0212830. 10.1371/journal.pone.0212830.
|
|
|
Ehler, J;
Petzold, A;
Wittstock, M;
Kolbaske, S;
Gloger, M;
Henschel, J;
Heslegrave, A;
... Sauer, M; + view all
(2019)
The prognostic value of neurofilament levels in patients with sepsis-associated encephalopathy - A prospective, pilot observational study.
PLoS One
, 14
(1)
, Article e0211184. 10.1371/journal.pone.0211184.
|
|
|
Fox, TA;
Lunn, M;
Wechalekar, A;
Bomanji, J;
Wan, S;
D'Sa, S;
(2018)
[18F]Florbetaben PET-CT confirms AL amyloidosis in a patient with Waldenström's Macroglobulinaemia.
Haematologica
, 103
(6)
10.3324/haematol.2017.184515.
|
|
|
Horga, A;
Laurà, M;
Jaunmuktane, Z;
Jerath, NU;
Gonzalez, MA;
Polke, JM;
Poh, R;
... Reilly, MM; + view all
(2017)
Genetic and clinical characteristics of NEFL-related Charcot-Marie-Tooth disease.
Journal of Neurology, Neurosurgery and Psychiatry
, 88
(7)
pp. 575-585.
10.1136/jnnp-2016-315077.
|
|
Kapoor, M;
Carr, AS;
Foiani, MS;
Heslegrave, AJ;
Zetterberg, H;
Malaspina, A;
Compton, L;
... Lunn, MP; + view all
(2022)
Association of plasma neurofilament light chain with disease activity in chronic inflammatory demyelinating polyradiculoneuropathy.
European Journal of Neurology
10.1111/ene.15496.
(In press).
|
|
|
Kapoor, M;
Reilly, MM;
Manji, H;
Lunn, MP;
Aisling, SC;
(2020)
Dramatic clinical response to ultra-high dose IVIg in otherwise treatment resistant inflammatory neuropathies.
International Journal of Neuroscience
10.1080/00207454.2020.1815733.
(In press).
|
|
Kapoor, M;
Foiani, M;
Heslegrave, A;
Zetterberg, H;
Lunn, MP;
Malaspina, A;
Gillmore, JD;
... Reilly, MM; + view all
(2019)
Plasma neurofilament light chain concentration is increased and correlates with the severity of neuropathy in hereditary transthyretin amyloidosis.
Journal of the Peripheral Nervous System
, 24
(4)
pp. 314-319.
10.1111/jns.12350.
|
|
Kapoor, M;
Rossor, AM;
Jaunmuktane, Z;
Lunn, MPT;
Reilly, MM;
(2018)
Diagnosis of amyloid neuropathy.
Practical Neurology
10.1136/practneurol-2018-002098.
(In press).
|
|
Kapoor, M;
Spillane, J;
Englezou, C;
Sarri-Gonzalez, S;
Bell, R;
Rossor, A;
Manji, H;
... Carr, A; + view all
(2019)
Thromboembolic risk with IVIg: Incidence and risk factors in inflammatory neuropathy patients.
Neurology
10.1212/WNL.0000000000008742.
(In press).
|
|
|
Karunaratne, K;
Ahrabian, D;
Monoghan, B;
Campion, T;
Yousry, T;
Lunn, MP;
Zandi, MS;
... Chataway, J; + view all
(2021)
Bortezomib for anti-NMDAR encephalitis following daclizumab treatment in a patient with multiple sclerosis.
BMJ Open Neurology
, 3
(1)
, Article e000096. 10.1136/bmjno-2020-000096.
|
|
|
Keddie, S;
Pakpoor, J;
Mousele, C;
Pipis, M;
Machado, PM;
Foster, M;
Record, CJ;
... Lunn, MP; + view all
(2021)
Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barré syndrome.
Brain
, 144
(2)
pp. 682-693.
10.1093/brain/awaa433.
|
|
Keddie, S;
Ziff, O;
Chou, MKL;
Taylor, RL;
Heslegrave, A;
Garr, E;
Lakdawala, N;
... Lunn, MP; + view all
(2020)
Laboratory biomarkers associated with COVID-19 severity and management.
Clinical Immunology
, 221
, Article 108614. 10.1016/j.clim.2020.108614.
|
|
Keddie, Stephen;
Smyth, Duncan;
Keh, Ryan YS;
Chou, Michael KL;
Grant, Donna;
Surana, Sunaina;
Heslegrave, Amanda;
... Lunn, Michael P; + view all
(2023)
Peripherin is a biomarker of axonal damage in peripheral nervous system disease.
Brain
10.1093/brain/awad234.
(In press).
|
|
Keddie, S;
Crisp, SJ;
Blackaby, J;
Cox, A;
Coles, A;
Hart, M;
Church, AJ;
... Lunn, MP; + view all
(2018)
Plasma cell depletion with bortezomib in the treatment of refractory N-methyl-d-aspartate (NMDA) receptor antibody encephalitis. Rational developments in neuroimmunological treatment.
European Journal of Neurology
, 25
(11)
pp. 1384-1388.
10.1111/ene.13759.
|
|
Keddie, S;
D'Sa, S;
Foldes, D;
Carr, AS;
Reilly, MM;
Lunn, MPT;
(2018)
POEMS neuropathy: optimising diagnosis and management.
Practical Neurology
10.1136/practneurol-2017-001792.
(In press).
|
|
|
Keddie, S;
D'Sa, S;
Lunn, MP;
(2019)
Advances in POEMS treatment and the need to define standardised outcome measures.
British Journal of Haematology
, 185
(2)
pp. 386-388.
10.1111/bjh.15529.
|
|
Keddie, S;
Fehmi, J;
Jaunmuktane, Z;
D'Sa, S;
Stevens, JC;
Lunn, MP;
(2019)
Untangling a case of painful neuropathy.
Practical Neurology
10.1136/practneurol-2019-002370.
(In press).
|
|
|
Keddie, S;
Foldes, D;
Caimari, F;
Baldeweg, SE;
Bomsztyk, J;
Ziff, OJ;
Fehmi, J;
... Lunn, MP; + view all
(2020)
Clinical characteristics, risk factors, and outcomes of POEMS syndrome: A longitudinal cohort study.
Neurology
, 95
(3)
e268-e279.
10.1212/WNL.0000000000009940.
|
|
Keddie, S;
Jaunmuktane, Z;
Brandner, S;
Shah, S;
Maddison, P;
Rees, JH;
Hanna, MG;
... Carr, AS; + view all
(2018)
A diagnostic conundrum.
Practical Neurology
, 18
(2)
pp. 137-142.
10.1136/practneurol-2017-001801.
|
|
|
Keddie, S;
Lunn, MP;
(2018)
POEMS syndrome.
Current Opinion in Neurology
, 31
(5)
pp. 551-558.
10.1097/WCO.0000000000000610.
|
|
|
Keddie, S;
Nagendran, A;
Cox, T;
Bomsztyk, J;
Jaunmuktane, Z;
Brandner, S;
Manji, H;
... Lunn, MP; + view all
(2020)
Peripheral nerve neurolymphomatosis: clinical features, treatment and outcomes.
Muscle & Nerve
, 62
(5)
pp. 617-625.
10.1002/mus.27045.
|
|
Keh, Ryan Yann Shern;
Lilleker, James B;
Lavin, Tim;
Sive, Jonathan;
D'Sa, Shirley;
Ramdharry, Gita;
Carr, Aisling S;
(2022)
Rasch-built overall disability scale for POEMS syndrome (POEMS-RODS).
Journal of the Peripheral Nervous System
, 27
(4)
pp. 302-310.
10.1111/jns.12516.
|
|
|
Keh, Ryan YS;
Scanlon, Sophie;
Datta-Nemdharry, Preeti;
Donegan, Katherine;
Cavanagh, Sally;
Foster, Mark;
Skelland, David;
... BPNS/ABN COVID-19 Vaccine GBS Study Group, .; + view all
(2023)
COVID-19 vaccination and Guillain-Barré syndrome: analyses using the National Immunoglobulin Database.
Brain
, 146
(2)
10.1093/brain/awac067.
|
|
Keh, R;
Kahlil, A;
Nihoyannopoulos, L;
Compton, L;
Kapoor, M;
Gosal, D;
Manji, H;
... Carr, AS; + view all
(2020)
Routine blood monitoring in maintenance immunoglobulin treatment of inflammatory neuropathy: Is it clinically relevant?
Journal of the Neurological Sciences
, 408
, Article 116527. 10.1016/j.jns.2019.116527.
|
|
Keshavan, Ashvini;
O'Shea, Frankie;
Chapman, Miles D;
Hart, Melanie S;
Lunn, Michael Pt;
Paterson, Ross W;
Rohrer, Jonathan D;
... Schott, Jonathan M; + view all
(2022)
CSF biomarkers for dementia.
Practical Neurology
10.1136/practneurol-2021-003310.
(In press).
|
|
Kinsella, JA;
Irani, SR;
Hollingsworth, R;
O'Shaughnessy, D;
Kane, P;
Foster, M;
Schott, JM;
(2018)
Use of intravenous immunoglobulin for the treatment of autoimmune encephalitis: audit of the NHS experience.
JRSM Open
, 9
(9)
pp. 1-5.
10.1177/2054270418793021.
|
|
|
Koay, S;
Vichayanrat, E;
Bremner, F;
Panicker, JN;
Lang, B;
Lunn, MP;
Watson, L;
... Iodice, V; + view all
(2021)
Multi-modal Biomarkers Quantify Recovery in Autoimmune Autonomic Ganglionopathy.
Annals of Neurology
, 89
(4)
pp. 753-768.
10.1002/ana.26018.
|
|
Koay, S;
Vichayanrat, E;
Bremner, F;
Valerio, F;
Mackenzie, R;
Chiaro, G;
Ingle, G;
... Iodice, V; + view all
(2025)
Multimodal Autonomic Biomarkers Predict Phenoconversion in Pure Autonomic Failure.
Annals of Clinical and Translational Neurology
10.1002/acn3.70140.
(In press).
|
|
|
Koay, Shiwen;
Chen, Yi-Chun;
Ransley, George;
Compton, Laura;
Lunn, Michael P;
Carr, Aisling S;
(2025)
Safety and Cost Analysis of Immunoglobulin Cessation Trials in Chronic Inflammatory Demyelinating Polyradiculoneuropathy.
Journal of the Peripheral Nervous System
, 30
(1)
, Article e70007. 10.1111/jns.70007.
|
|
|
Lunn, M;
(2021)
Preventing expensive harms in Guillain-Barré syndrome.
The Lancet Neurology
, 20
(4)
pp. 249-251.
10.1016/S1474-4422(21)00041-7.
|
|
Lunn, M;
Carr, A;
Keddie, S;
pakpoor, J;
Pipis, M;
Willison, H;
(2021)
Reply: Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barré syndrome.
Brain
, 144
(5)
, Article e47. 10.1093/brain/awab070.
|
|
Lunn, Michael;
Smyth, Duncan;
(2026)
Prospective assessment of serum neurofilament light chain in platinum- and taxane-induced peripheral neuropathy.
BMJ Neurology Open
(In press).
|
|
Lunn, MP;
Cornblath, DR;
Jacobs, BC;
Querol, L;
Van Doorn, PA;
Hughes, RA;
Willison, HJ;
(2021)
COVID-19 vaccine and Guillain-Barré syndrome: let’s not leap to associations.
Brain
, 144
(2)
pp. 357-360.
10.1093/brain/awaa444.
|
|
Lunn, M;
(2021)
Intravenous immunoglobulin treatment for mild Guillain-Barré syndrome: an international observational study.
Journal of Neurology, Neurosurgery, and Psychiatry
10.1136/jnnp-2020-325815.
(In press).
|
|
|
Lunn, MP;
(2019)
Neuropathies and paraproteins.
Current Opinion in Neurology
, 32
(5)
pp. 658-665.
10.1097/WCO.0000000000000726.
|
|
Marsh, ES;
Keddie, S;
Terris-Prestholt, F;
D'Sa, S;
Lunn, MP;
(2020)
Early VEGF testing in inflammatory neuropathy avoids POEMS syndrome misdiagnosis and associated costs.
Journal of Neurology, Neurosurgery & Psychiatry
10.1136/jnnp-2020-324012.
(In press).
|
|
|
McGonigal, Rhona;
Cunningham, Madeleine E;
Smyth, Duncan;
Chou, Michael;
Barrie, Jennifer A;
Wilkie, Andrew;
Campbell, Clare;
... Willison, Hugh J; + view all
(2023)
The endogenous calpain inhibitor calpastatin attenuates axon degeneration in murine Guillain-Barré syndrome.
Journal of the Peripheral Nervous System
, 28
(1)
pp. 4-16.
10.1111/jns.12520.
|
|
Mok, Tze How;
Nihat, Akin;
Majbour, Nour;
Sequeira, Danielle;
Holm-Mercer, Leah;
Coysh, Thomas;
Darwent, Lee;
... Mead, Simon; + view all
(2023)
Seed amplification and neurodegeneration marker trajectories in individuals at risk of prion disease.
Brain
, Article awad101. 10.1093/brain/awad101.
|
|
|
Nethisinghe, S;
Lim, WN;
Ging, H;
Zeitlberger, A;
Abeti, R;
Pemble, S;
Sweeney, MG;
... Giunti, P; + view all
(2018)
Complexity of the Genetics and Clinical Presentation of Spinocerebellar Ataxia 17.
Frontiers in Cellular Neuroscience
, 12
, Article 429. 10.3389/fncel.2018.00429.
|
|
|
Paterson, RW;
Benjamin, LA;
Mehta, PR;
Brown, RL;
Athauda, D;
Ashton, NJ;
Leckey, CA;
... Schott, JM; + view all
(2021)
Serum and cerebrospinal fluid biomarker profiles in acute SARS-CoV-2-associated neurological syndromes.
Brain Communications
, 3
(3)
, Article fcab099. 10.1093/braincomms/fcab099.
|
|
|
Paterson, RW;
Brown, RL;
Benjamin, L;
Nortley, R;
Wiethoff, S;
Bharucha, T;
Jayaseelan, DL;
... UCL Queen Square National Hospital for Neurology and Neurosurger; + view all
(2020)
The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings.
Brain
10.1093/brain/awaa240.
(In press).
|
|
|
Paterson, RW;
Slattery, CF;
Poole, T;
Nicholas, JM;
Magdalinou, NK;
Toombs, J;
Chapman, MD;
... Schott, JM; + view all
(2018)
Cerebrospinal fluid in the differential diagnosis of Alzheimer's disease: clinical utility of an extended panel of biomarkers in a specialist cognitive clinic.
Alzheimer's Research & Therapy
, 10
, Article 32. 10.1186/s13195-018-0361-3.
|
|
Paterson, RW;
Toombs, J;
Chapman, MD;
Nicholas, JM;
Heslegrave, AJ;
Slattery, CF;
Foulkes, AJM;
... Schott, JM; + view all
(2015)
Do cerebrospinal fluid transfer methods affect measured amyloid β42, total tau, and phosphorylated tau in clinical practice?
Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring
, 1
(3)
pp. 380-384.
10.1016/j.dadm.2015.06.003.
|
|
|
Pihan, M;
Keddie, S;
D'Sa, S;
Church, AJ;
Yong, KL;
Reilly, MM;
Lunn, MP;
(2018)
Raised VEGF: High sensitivity and specificity in the diagnosis of POEMS syndrome.
Neurology, Neuroimmunology & Neuroinflammation
, 5
(5)
, Article e486. 10.1212/NXI.0000000000000486.
|
|
|
Pipis, Menelaos;
Jaunmuktane, Zane;
Marafioti, Teresa;
Brandner, Sebastian;
Smith, Elaine C;
D'Sa, Shirley;
Lunn, Michael P;
... Reilly, Mary M; + view all
(2024)
Nerve biopsy in T-cell lymphoma with neurolymphomatosis: where and when.
Practical Neurology
10.1136/pn-2023-003992.
(In press).
|
 |
|
Record, Christopher;
Pipis, Menelaos;
Curro, riccardo;
Blake, Julian;
Lunn, Michael;
Rossor, Alexander;
Laura, matilde;
... Reilly, mary; + view all
(2022)
Unusual upper limb features in SORD neuropathy.
Journal of the Peripheral Nervous System
, 27
(2)
pp. 175-177.
10.1111/jns.12492.
|
|
Ross Russell, AL;
Hardwick, M;
Jeyanantham, A;
White, LM;
Deb, S;
Burnside, G;
Joy, HM;
... Galea, I; + view all
(2021)
Spectrum, risk factors and outcomes of neurological and psychiatric complications of COVID-19: a UK-wide cross-sectional surveillance study.
Brain Communications
, 3
(3)
, Article fcab168. 10.1093/braincomms/fcab168.
|
|
|
Sayar, Z;
Weatherill, A;
Keddie, S;
Sive, J;
Lunn, MP;
Thomas, M;
D'Sa, S;
(2020)
High rates of venous and arterial thrombotic events in patients with POEMS syndrome: results from the UCLH (UK) POEMS Registry.
Blood advances
, 4
(10)
pp. 2139-2142.
10.1182/bloodadvances.2020001492.
|
|
Schwingenschuh, P;
Saifee, TA;
Katschnig-Winter, P;
Reilly, MM;
Lunn, MP;
Manji, H;
Aguirregomozcorta, M;
... Edwards, MJ; + view all
(2013)
Cerebellar learning distinguishes inflammatory neuropathy with and without tremor.
Neurology
, 80
(20)
1867 - 1873.
10.1212/WNL.0b013e318292a2b8.
|
|
|
Sommerlad, A;
Duncan, J;
Lunn, MPT;
Foong, J;
(2015)
Neuropsychiatric systemic lupus erythematosus: a diagnostic challenge.
BMJ Case Reports
, 2015
10.1136/bcr-2014-208215.
|
|
|
Tomkins, Oliver;
Khwaja, Jahanzaib;
Koay, Shiwen;
Japzon, Nicole;
Hoskote, Chandrashekar;
Gupta, Rajeev;
Baker, Robert;
... D'Sa, Shirley; + view all
(2025)
Bing-Neel Syndrome - A Case Series of 46 Patients from the United Kingdom.
Blood Advances
10.1182/bloodadvances.2025016360.
(In press).
|
|
|
Tomkins, O;
Keddie, S;
Lunn, MP;
D'Sa, S;
(2019)
High-dose therapy and autologous transplantation for POEMS Syndrome: effective, but how to optimise?
British Journal of Haematology
, 186
(6)
e178-e181.
10.1111/bjh.16057.
|
|
Toombs, J;
Foiani, MS;
Paterson, RW;
Heslegrave, A;
Wray, S;
Schott, JM;
Fox, NC;
... Zetterberg, H; + view all
(2017)
Effect of Spinal Manometers on Cerebrospinal Fluid Amyloid-beta Concentration.
Journal of Alzheimer's Disease
, 56
(3)
pp. 885-891.
10.3233/JAD-161126.
|
|
Toombs, J;
Foiani, MS;
Wellington, H;
Paterson, RW;
Arber, C;
Heslegrave, A;
Lunn, MP;
... Zetterberg, H; + view all
(2018)
Amyloid β peptides are differentially vulnerable to preanalytical surface exposure, an effect incompletely mitigated by the use of ratios.
Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring
, 10
pp. 311-321.
10.1016/j.dadm.2018.02.005.
|
|
|
van den Bergh, P;
Blomkwist-Markens, P;
Cornblath, D;
D'Sa, S;
Faber, C;
Goedee, S;
Gorson, K;
... Willison, H; + view all
(2017)
230th ENMC International Workshop:: Improving future assessment and research in IgM anti-MAG peripheral neuropathy: A consensus collaborative effort, Naarden, The Netherlands, 24–26 February 2017.
Neuromuscular Disorders
, 27
(11)
pp. 1065-1072.
10.1016/j.nmd.2017.08.001.
|
|
|
Varley, James A;
Champsas, Dimitrios;
Prossor, Timothy;
Pontillo, Giuseppe;
Abdel-Mannan, Omar;
Khaleeli, Zhaleh;
Petzold, Axel;
... Ciccarelli, Olga; + view all
(2024)
Validation of the 2023 International Diagnostic
Criteria for MOGAD in a Selected Cohort of Adults
and Children.
Neurology
, 103
(1)
10.1212/WNL.0000000000209321.
|
|
Vos, JM;
Notermans, NC;
D'Sa, S;
Lunn, MP;
van der Pol, WL;
Kraan, W;
Reilly, MM;
... Minnema, MC; + view all
(2017)
High prevalence of the MYD88 L265P mutation in IgM anti-MAG paraprotein-associated peripheral neuropathy.
[Letter].
Journal of Neurology, Neurosurgery & Psychiatry
, 89
(9)
pp. 1007-1009.
10.1136/jnnp-2017-316689.
|
|
|
Weston, PS;
Paterson, RW;
Dickson, J;
Barnes, A;
Bomanji, JB;
Kayani, I;
Lunn, MP;
... Schott, JM; + view all
(2016)
Diagnosing Dementia in the Clinical Setting: Can Amyloid PET Provide Additional Value Over Cerebrospinal Fluid?
Journal of Alzheimer's Disease
, 54
(4)
pp. 1297-1302.
10.3233/JAD-160302.
|
|
Weston, PS;
Paterson, RW;
Modat, M;
Burgos, N;
Cardoso, MJ;
Magdalinou, N;
Lehmann, M;
... Schott, JM; + view all
(2015)
Using florbetapir positron emission tomography to explore cerebrospinal fluid cut points and gray zones in small sample sizes.
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
, 1
(4)
pp. 440-446.
10.1016/j.dadm.2015.10.001.
|
|
|
Wieske, L;
Smyth, D;
Lunn, MP;
Eftimov, F;
Teunissen, CE;
(2021)
Fluid Biomarkers for Monitoring Structural Changes in Polyneuropathies: Their Use in Clinical Practice and Trials.
Neurotherapeutics
10.1007/s13311-021-01136-0.
(In press).
|
|
|
Zambreanu, L;
Lightbody, S;
Bhandari, M;
Hoskote, C;
Kandil, H;
Houlihan, CF;
Lunn, MP;
(2020)
A case of limbic encephalitis associated with asymptomatic COVID-19 infection.
Journal Of Neurology Neurosurgery And Psychiatry
, 91
(11)
pp. 1229-1230.
10.1136/jnnp-2020-323839.
|
|
|
Zetterberg, H;
Alawode, D;
Keshavan, A;
o'connor, A;
Weston, P;
Paterson, R;
Heslegrave, A;
... Schott, J; + view all
(2020)
Blood Tests for Alzheimer Disease.
Practical Neurology
|
|
|
Ziff, OJ;
Hoskote, C;
Keddie, S;
D'Sa, S;
Davangnanam, I;
Lunn, MPT;
(2019)
Frequent central nervous system, pachymeningeal and plexus MRI changes in POEMS syndrome.
Journal of Neurology
, 266
(5)
pp. 1067-1072.
10.1007/s00415-019-09233-z.
|
